SomaSense
Somatosensory Mapping and Monitoring for Rehabilitation and ADL Support
Company Overview
Snapshot
Founded in February 2024 by Roee Madai, SomaSense operates with 1–10 employees. The company has secured one non-equity funding round, receiving a grant in January 2025.
Business overview
SomaSense develops technology focused on mapping somatosensory deficits to enhance rehabilitation and daily function monitoring. The company's core product standardizes sensory data collection and integrates with home devices, allowing patients to track progress and clinicians to personalize treatment. Operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices, SomaSense aims to improve patient outcomes, facilitate communication between patients and care systems, and reduce rehabilitation time by providing actionable insights into sensory recovery.
Company Intelligence Q&A
- When was SomaSense founded?
- SomaSense was founded in February 2024 by Roee Madai.
- What is SomaSense's primary focus?
- SomaSense focuses on developing technology for mapping somatosensory deficits to support rehabilitation and daily function monitoring, aiming to improve patient outcomes and personalize treatment.
- What type of funding has SomaSense received?
- SomaSense received a non-equity grant in January 2025.
- Who is the founder of SomaSense?
- Roee Madai is the founder and CEO of SomaSense.
- What markets does SomaSense serve?
- SomaSense serves the Health Tech & Life Sciences sector, specifically within Medical Devices and Digital Healthcare, with a focus on patient remote monitoring and diagnostics devices.